Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmachim is a prominent Bulgarian pharmaceutical company with a long history as a state-owned conglomerate that once dominated the Eastern European drug market. Today, it operates as a holding company and commercial entity focused on the production, export, and trade of generic pharmaceuticals, phytopharmaceuticals, and cosmetic products. The company provides a wide range of finished dosage forms, including tablets, capsules, and ampoules, and maintains a significant presence in international markets through its distribution networks. Pharmachim also offers contract manufacturing services, leveraging its established infrastructure to produce high-quality medicinal products in compliance with international standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmachim.